Fusun Saygili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fusun Saygili has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Candeger Yilmaz
Department of Endocrinology, Ege University School of Medicine, Izmir, Turkey
2 shared publications - Sevki Cetinkalp
Department of Endocrinology and Metabolic DiseasesSchool of MedicineEge University Izmir Turkey
2 shared publications - Afig Berdeli
EGE UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC RHEUMATOLOGY
1 shared publication - Ahmet Gokhan Ozgen
Ege Univ, Sch Med, Dept Endocrinol & Metab, Izmir, Turkiye
1 shared publication Asli Kisim
1 shared publication- Aslı Tetik Vardarlı
Department of Medical Biology, Faculty of Medicine Ege University Izmir Türkiye
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 5 (10) , 734-736
A case of polyostotic fibrous dysplasia leading to multiple deformities
Fibrous dysplasia (FD) is a rare disease leading to increased bone resorption due to abnormal fibroblast proliferation and defective osteoblast differentiation. As it can be asymptomatic, FD can also cause bone pain, deformity and compression symptoms. Fibrous dysplasia can present itself in either a monostotic form, with involvement of one bone site, or a polyostotic form that includes multiple bone sites. Monostotic forms comprise 70
- 1 January 2014
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 5 (10) , 734-736
Open AccessA case of polyostotic fibrous dysplasia leading to multiple deformities
Fibrous dysplasia (FD) is a rare disease leading to increased bone resorption due to abnormal fibroblast proliferation and defective osteoblast differentiation. As it can be asymptomatic, FD can also cause bone pain, deformity and compression symptoms. Fibrous dysplasia can present itself in either a monostotic form, with involvement of one bone site, or a polyostotic form that includes multiple bone sites. Monostotic forms comprise 70
- Open Access
- 1 January 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 193
Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome
Obesity, insulin resistance and hyperandrogenism, crucial parameters of Polycystic ovary syndrome (PCOS) play significant pathophysiological roles in lipidemic aberrations associated within the syndrome. Parts of the metabolic syndrome (low HDL and insulin resistance) appeared to facilitate the association between PCOS and coronary artery disease, independently of obesity. ABCA1 gene polymorphism may be altered this components in PCOS patients. In this study, we studied 98 PCOS patients and 93 healthy controls. All subjects underwent venous blood drawing for complete hormonal assays, lipid profile, glucose, insulin, malondialdehyde, nitric oxide, disulfide levels and ABCA genetic study. In PCOS group fasting glucose, DHEAS, 17-OHP, free testosterone, total-cholesterol, triglyceride, LDL-cholesterol and fibrinogen were significantly different compare to controls. The genotype ABCA G2706A distribution differed between the control group (GG 60.7%, GA 32.1%, AA 7.1%) and the PCOS patients (GG 8.7%, GA 8.7%, AA 76.8%). The frequency of the A allele (ABCAG2706A) was higher in PCOS patients than control group with 13,0% and 23,2%, respectively. In this study, the homocystein and insulin levels were significantly higher in PCOS patients with ABCA G1051A mutant genotype than those with heterozygote and wild genotypes. We found higher percentage of AA genotype and A allele of ABCA G2706A in PCOS patients compare to controls. The fasting insulin and homocystein levels were significantly higher in PCOS patients with ABCA G1051A mutant genotype than those with heterozygote and wild genotypes.
- 1 January 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 193
Open AccessEffect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome
Obesity, insulin resistance and hyperandrogenism, crucial parameters of Polycystic ovary syndrome (PCOS) play significant pathophysiological roles in lipidemic aberrations associated within the syndrome. Parts of the metabolic syndrome (low HDL and insulin resistance) appeared to facilitate the association between PCOS and coronary artery disease, independently of obesity. ABCA1 gene polymorphism may be altered this components in PCOS patients. In this study, we studied 98 PCOS patients and 93 healthy controls. All subjects underwent venous blood drawing for complete hormonal assays, lipid profile, glucose, insulin, malondialdehyde, nitric oxide, disulfide levels and ABCA genetic study. In PCOS group fasting glucose, DHEAS, 17-OHP, free testosterone, total-cholesterol, triglyceride, LDL-cholesterol and fibrinogen were significantly different compare to controls. The genotype ABCA G2706A distribution differed between the control group (GG 60.7%, GA 32.1%, AA 7.1%) and the PCOS patients (GG 8.7%, GA 8.7%, AA 76.8%). The frequency of the A allele (ABCAG2706A) was higher in PCOS patients than control group with 13,0% and 23,2%, respectively. In this study, the homocystein and insulin levels were significantly higher in PCOS patients with ABCA G1051A mutant genotype than those with heterozygote and wild genotypes. We found higher percentage of AA genotype and A allele of ABCA G2706A in PCOS patients compare to controls. The fasting insulin and homocystein levels were significantly higher in PCOS patients with ABCA G1051A mutant genotype than those with heterozygote and wild genotypes.
- Open Access
- 1 January 2007
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 6 (1) , 29
The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
Women with PCOS have been reported to be at increased risk of a number of gynaecological neoplasias, including endometrial, breast, and ovarian cancer. Studies of the possible association of genetic variation in progesterone receptor polymorphism with risk of ovarian and breast cancer have concentrated on a variant known as PROGINS.
- 1 January 2007
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 6 (1) , 29
Open AccessThe progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
Women with PCOS have been reported to be at increased risk of a number of gynaecological neoplasias, including endometrial, breast, and ovarian cancer. Studies of the possible association of genetic variation in progesterone receptor polymorphism with risk of ovarian and breast cancer have concentrated on a variant known as PROGINS.